Summary
The broader/commercial impact of this Small Business Innovation Research Phase I project will be focused on a transformational approach to real-time quality assurance in injectable drug manufacturing by introducing a compact, low-cost and scalable sensor capable of detecting both particulate matter (PM) and microbial contaminants inline. Leveraging recent advances in imaging and machine learning, the system delivers automated, label-free particle analysis with high sensitivity and throughput. While standard quality tests are typically conducted offline and manually, this new technology fills a
